scholarly journals Genetic Counseling, Personalized Medicine, and Precision Health

2019 ◽  
Vol 10 (9) ◽  
pp. a036699 ◽  
Author(s):  
Erica Ramos
Allergy ◽  
2019 ◽  
Vol 75 (4) ◽  
pp. 936-940 ◽  
Author(s):  
Oscar Palomares ◽  
Eva Untersmayr ◽  
Jan Gutermuth ◽  
Ioana Agache ◽  
Sofia Ajeganova ◽  
...  

Author(s):  
Kirsty McWalter ◽  
Megan T. Cho ◽  
Tara Hart ◽  
Rachel Nusbaum ◽  
Courtney Sebold ◽  
...  

2020 ◽  
Vol 10 (2) ◽  
pp. 29 ◽  
Author(s):  
Tara Schmidlen ◽  
Amy Sturm ◽  
Laura Scheinfeldt

As pharmacogenomic (PGx) use in healthcare increases, a better understanding of patient needs will be necessary to guide PGx result delivery. The Coriell Personalized Medicine Collaborative (CPMC) is a prospective study investigating the utility of personalized medicine. Participants received online genetic risk reports for 27 potentially actionable complex diseases and 7 drug–gene pairs and could request free, telephone-based genetic counseling (GC). To explore the needs of individuals receiving PGx results, we conducted a retrospective qualitative review of inquiries from CPMC participants who requested counseling from March 2009 to February 2017. Eighty out of 690 (12%) total GC inquiries were focused on the discussion of PGx results, and six salient themes emerged: “general help”, “issues with drugs”, “relevant disease experience”, “what do I do now?”, “sharing results”, and “other drugs”. The number of reported medications with a corresponding PGx result and participant engagement were significantly associated with PGx GC requests (p < 0.01 and p < 0.02, respectively). Our work illustrates a range of questions raised by study participants receiving PGx test results, most of which were addressed by a genetic counselor with few requiring referrals to prescribing providers or pharmacists. These results further support a role for genetic counselors in the team-based approach to optimal PGx result delivery.


2020 ◽  
Vol 34 (3) ◽  
pp. 235-237
Author(s):  
Paul E. Terry

The prospect that modifying just one mutated letter in a genomic sequence could save millions of lives has spawned a growing discipline called personalized medicine (PM). Where PM focuses on bringing greater precision to individual treatments, the genetics revolution also invites questions about how genetics testing and genetics reference panels can be applied in a public health context. Some voice concerns that the growth of PM will shift us back to an emphasis on the medical model for health advancement with undue focus and investment on individual rather than societal solutions. This editorial introduces precision health promotion and defines it as “the personalized design of lived experiences that foster improved health and well-being for individuals within the context of their families, organizations and communities.”


Author(s):  
В.А. Румянцева ◽  
Е.В. Заклязьминская

Анализ результатов 10-летней работы лаборатории медицинской генетики показал необходимость развития новых отраслей генетики для формирования персонализированной медицины в России. Совершенствование медико-генетической службы на базе многопрофильного хирургического центра дает большие преимущества в развитии семейных обследований. The analysis of last 10 years work experience of medical genetics laboratory has shown the need for the development of new branches of genetics for the formation of personalized medicine in Russia. The improvement of the medical genetic services at the multidisciplinary surgical center provides great advantages in the development of family examinations.


Sign in / Sign up

Export Citation Format

Share Document